Hormone Receptors and Signaling

Hormone Receptors and Signaling

Hormone Receptors and Signaling

On this page

Receptor Classification - Meet the Handlers

  • Cell Surface Receptors (Rapid action; for Peptides, Catecholamines)
    • G-Protein Coupled Receptors (GPCRs): Largest family (e.g., ACTH, TSH, Glucagon). Utilize G proteins (Gs, Gi, Gq).
    • Enzyme-Linked Receptors:
      • Receptor Tyrosine Kinases (RTKs): Insulin, IGF-1. Possess intrinsic kinase activity.
      • JAK-STAT Pathway Receptors: Growth Hormone, Prolactin. Recruit Janus Kinase (JAK).
    • Ion Channel-Linked Receptors: e.g., Nicotinic Acetylcholine (ACh) receptor.
  • Intracellular Receptors (Slower action, alter gene expression; for Steroids, Thyroid Hormones, Vitamin D)
    • Cytoplasmic (Type I): Steroid hormones (e.g., Cortisol, Aldosterone, Estrogen). Bind hormone, then translocate to nucleus.
    • Nuclear (Type II): Thyroid hormones, Vitamin D, Retinoids. Often pre-bound to DNA within the nucleus.

⭐ Thyroid hormone receptors (TRs) are typically found in the nucleus, already bound to DNA at Hormone Response Elements (HREs), often acting as repressors in the absence of the hormone ligand.

Membrane Receptor Pathways - Surface Stars

  • G-Protein Coupled Receptors (GPCRs): 7-transmembrane. Ligand → G-protein (α,β,γ) activation.

    • Gs: ↑ Adenylyl Cyclase → ↑ cAMP → PKA. (Glucagon, β-receptors).
    • Gi: ↓ Adenylyl Cyclase → ↓ cAMP. (Somatostatin, α2-receptors).
    • Gq: ↑ PLC → IP3 (↑ $Ca^{2+}$) + DAG (PKC). (GnRH, α1-receptors).
    • 📌 Mnemonic: Gs (Stimulates AC), Gi (Inhibits AC), Gq (PLC for $Ca^{2+}$ Quick!).
  • Enzyme-Linked Receptors:

    • Receptor Tyrosine Kinases (RTKs): Insulin, IGF-1. Dimerization → Autophosphorylation → MAP Kinase/PI3K.
    • JAK-STAT Pathway: GH, Prolactin. Receptor + JAK → STAT phosphorylation → Gene transcription.
    • Receptor Guanylyl Cyclases: ANP, BNP → ↑ cGMP.
  • Ion Channel-Linked Receptors: Nicotinic ACh, GABA-A. Rapid ion flux.

⭐ Insulin receptor is a Receptor Tyrosine Kinase (RTK) with intrinsic kinase activity, mediating glucose uptake and anabolic effects.

Intracellular Receptor Action - Inside Job

  • Ligands: Lipophilic (steroids, thyroid hormones, Vit D). Diffuse across cell membrane.
  • Receptor Location: Cytoplasm (Type I) or Nucleus (Type II).
  • Action Pathway:
    • Hormone binds receptor (Heat Shock Protein dissociation for Type I).
    • Hormone-Receptor (H-R) complex translocates to nucleus (if cytoplasmic).
    • H-R complex binds DNA at Hormone Response Elements (HREs).
    • Alters gene transcription → new protein synthesis.
    • Result: Slow onset, prolonged effects.
  • Receptor Classes:
    • Type I (Steroid): e.g., Glucocorticoid (GR), Mineralocorticoid (MR), Estrogen (ER), Progesterone (PR), Androgen (AR). Cytoplasmic; form homodimers.
    • Type II (Thyroid/Vit D/Retinoid): e.g., Thyroid (TR), Vitamin D (VDR), Retinoic Acid (RAR). Nuclear; form heterodimers (often with RXR).

    ⭐ Thyroid hormone receptors (TRs) are often pre-bound to DNA in the nucleus with corepressors; ligand binding swaps corepressors for coactivators.

  • 📌 Mnemonic: "Steroids Seek Cytoplasm, Thyroid Targets Nucleus."

Second Messengers & Regulation - Signal Controls

  • Key Second Messengers & Actions:
    • cAMP: Activates Protein Kinase A (PKA).
    • cGMP: Activates Protein Kinase G (PKG).
    • IP₃ (Inositol Trisphosphate): Releases Ca²⁺ from ER, ↑ cytosolic Ca²⁺.
    • DAG (Diacylglycerol): Activates Protein Kinase C (PKC) with Ca²⁺.
    • Ca²⁺: Binds calmodulin, then activates CaM-Kinases.
  • Signal Control & Regulation:
    • Desensitization: Rapid ↓ receptor response. Homologous (e.g., GRKs, β-arrestin) or Heterologous (e.g., PKA/PKC).
    • Down-regulation: ↓ total receptor number (internalization & degradation).
    • Up-regulation: ↑ total receptor number (e.g., prolonged ligand absence).
    • Termination: Ligand dissociation/degradation, Gα GTPase activity, phosphodiesterase breakdown of cAMP/cGMP. G protein-coupled receptor signaling pathway

⭐ Chronic agonist exposure often leads to receptor down-regulation, a slower adaptive process than desensitization, reducing cellular responsiveness.

High‑Yield Points - ⚡ Biggest Takeaways

  • GPCRs are the largest receptor family; utilize cAMP, IP3/DAG as key second messengers.
  • Insulin and growth factors act via receptor tyrosine kinases (RTKs), involving autophosphorylation.
  • Steroid and thyroid hormones bind intracellular receptors, directly modulating gene expression.
  • Gs proteins stimulate adenylyl cyclase (↑cAMP); Gi inhibits it; Gq activates phospholipase C (↑IP3/DAG, Ca²⁺).
  • Receptor desensitization or downregulation diminishes hormone response with prolonged exposure.
  • Hormone resistance can arise from defects in receptors or post-receptor signaling pathways.

Practice Questions: Hormone Receptors and Signaling

Test your understanding with these related questions

Insulin acts by which pathway-

1 of 5

Flashcards: Hormone Receptors and Signaling

1/10

The hormone sensitivity (responsiveness) of a target tissue may be changed in two ways: 1. Change the _____ of receptors 2. Change the affinity of receptors

TAP TO REVEAL ANSWER

The hormone sensitivity (responsiveness) of a target tissue may be changed in two ways: 1. Change the _____ of receptors 2. Change the affinity of receptors

number

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial